{
    "symbol": "RPRX",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-15 13:49:04",
    "content": " Thanks for your question, Chris. Thanks for your question, Chris. But one thing to just remember is that Royalty Pharma compared to many, many other businesses in life sciences has something which is really, really unique that I think is not appreciated well by many investors or it's sort of underappreciated which is the fact that we come in and make these investments with a very, very attractive risk/reward profile because we're coming in with -- first of all, with the approved product."
}